ADA Scientific Sessions 2025 Abstract

A Novel Antibody–Peptide Conjugate Targeting PCSK9,GLP-1R,GCGR,GIPR Improves Cardiovascular Risk Markers in Preclinical Study

By Decheng Ren, Yiming Li

Experiments in animalsInterventions

The paper

Decheng Ren, Yiming Li

Suzhou

ADA Scientific Sessions 2025 Abstract, 13 Jun 2025

Presented at ADA Scientific Sessions 2025, late-breaking 1886-LB

doi.org/10.2337/db25-1886-lb

Cell Metabolism8 Oct 2026
A triple-target drug cut body weight by up to 19.7% in a trial
Research Square8 Oct 2026
Semaglutide improved heart artery function in pigs
Lancet4 Oct 2026
Orforglipron matches insulin glargine on cardiovascular safety
The New England Journal of Medicine4 Oct 2026
Survodutide reduces weight in adults with diabetes and obesity